Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2021 · 10-Q
Revenue$195.58M$195.58M−18.0% vs Q1 2020 Net Income$10.53M$10.53MN/M vs Q1 2020 EPS Diluted$0.21$0.21N/M vs Q1 2020 Gross Profit$90,030,000−22.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow$11,812,000+349.5% Free Cash Flowderived$4,116,000N/M Margins · derivedGross margin46.0%−2.6 pt vs Q1 2020
Operating margin6.0%+11.6 pt vs Q1 2020
Net margin5.4%+8.9 pt vs Q1 2020
ended Jun 27, 2020 · filed Aug 4, 2020 · 38 d after period end